Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1

Virology

Volumn 396, Issue 2, 2010, Pages 203-212

  Jin, Qingwen ^a   Alkhatib, Bashar ^b   Cornetta, Kenneth ^a   Alkhatib, Ghalib ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Biology   (United States)

Author keywords

HTLV 1; Neuropilin 1; Neurotropism; Virus entry

Indexed keywords

GLUCOSE TRANSPORTER; NEUROPILIN 1; SMALL INTERFERING RNA; VASCULOTROPIN 165;

ANIMAL CELL; ARTICLE; ASTROCYTE; COMPLEX FORMATION; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; VIRUS ENTRY;

ANIMALS; ASTROCYTES; CELL LINE; CELL TRANSFORMATION, VIRAL; CHO CELLS; CRICETINAE; CRICETULUS; DOWN-REGULATION; GLUCOSE TRANSPORTER TYPE 1; HELA CELLS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; NEUROPILIN-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 70749113196     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.10.015     Document Type: Article

References (39)

1. Agrawal L., Vanhorn-Ali Z., and Alkhatib G. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs). J. Leukoc. Biol. 72 5 (2002) 1063-1074
2. Agrawal L., Lu X., Qingwen J., VanHorn-Ali Z., Nicolescue V., McDermott D., Murphy P.M., and Alkhatib G. Role for CCR5D32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells. J. Virol. 78 5 (2004) 2277-2287
3. Agrawal L., VanHorn-Ali Z., Berger E.A., and Alkhatib G. Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5. Blood 103 4 (2004) 1211-1217
4. Agrawal L., Lu X., Jin Q., and Alkhatib G. Anti-HIV therapy: current and future directions. Curr. Pharm. Des. 12 16 (2006) 2031-2055
5. Altmeyer R. Virus attachment and entry offer numerous targets for antiviral therapy. Curr. Pharm. Des. 10 30 (2004) 3701-3712
6. Ceccaldi P.E., Delebecque F., Prevost M.C., Moris A., Abastado J.P., Gessain A., Schwartz O., and Ozden S. DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells. J. Virol. 80 10 (2006) 4771-4780
7. Daenke S., McCracken S.A., and Booth S. Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7. J. Gen. Virol. 80 Pt 6 (1999) 1429-1436
8. Feuer G., and Green P.L. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24 39 (2005) 5996-6004
9. Gallo R.C. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 24 39 (2005) 5926-5930
10. Ghez D., Lepelletier Y., Lambert S., Fourneau J.-M., Blot V., Janvier S., Arnulf B., Endert P.M., Heveker N., Pique C., and Hermine O. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J. Virol. 80 14 (2006) 6844-6854
11. Guttmann-Raviv N., Kessler O., Shraga-Heled N., Lange T., Herzog Y., and Neufeld G. The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett. 231 1 (2006) 1-11
12. He Z., and Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90 4 (1997) 739-751
13. Hildreth J.E., Subramanium A., and Hampton R.A. Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology. J. Virol. 71 2 (1997) 1173-1180
14. Jin Q., Agrawal L., Vanhorn-Ali Z., and Alkhatib G. GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1. Virology (2006)
15. Jin Q., Agrawal L., Vanhorn-Ali Z., and Alkhatib G. Infection of CD4(+) T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain. Virology 349 1 (2006) 184-196
16. Jones K.S., Petrow-Sadowski C., Bertolette D.C., Huang Y., and Ruscetti F.W. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J. Virol. 79 20 (2005) 12692-12702
17. Jones K.S., Fugo K., Petrow-Sadowski C., Huang Y., Bertolette D.C., Lisinski I., Cushman S.W., Jacobson S., and Ruscetti F.W. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J. Virol. 80 17 (2006) 8291-8302
18. Jones K.S., Petrow-Sadowski C., Huang Y.K., Bertolette D.C., and Ruscetti F.W. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat. Med. 14 4 (2008) 429-436
19. Kolodkin A.L., Levengood D.V., Rowe E.G., Tai Y.T., Giger R.J., and Ginty D.D. Neuropilin is a semaphorin III receptor. Cell 90 4 (1997) 753-762
20. Krilleke D., DeErkenez A., Schubert W., Giri I., Robinson G.S., Ng Y.S., and Shima D.T. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 282 38 (2007) 28045-28056
21. Lambert S., Bouttier M., Vassy R., Seigneuret M., Petrow-Sadowski C., Janvier S., Heveker N., Ruscetti F.W., Perret G., Jones K.S., and Pique C. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood 113 21 (2009) 5176-5185
22. Liu J., and Thorp S.C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22 1 (2002) 1-25
23. Manel N., Kim F.J., Kinet S., Taylor N., Sitbon M., and Battini J.L. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115 4 (2003) 449-459
24. Manel N., Battini J.L., Taylor N., and Sitbon M. HTLV-1 tropism and envelope receptor. Oncogene 24 39 (2005) 6016-6025
25. Mendes-da-Cruz D.A., Lepelletier Y., Brignier A.C., Smaniotto S., Renand A., Milpied P., Dardenne M., Hermine O., and Savino W. Neuropilins, semaphorins, and their role in thymocyte development. Ann. N. Y. Acad. Sci. 1153 (2009) 20-28
26. Narazaki M., and Tosato G. Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 107 10 (2006) 3892-3901
27. Narazaki M., Segarra M., and Tosato G. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood 111 8 (2008) 4126-4136
28. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13 1 (1999) 9-22
29. Nussbaum O., Broder C.C., and Berger E.A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68 (1994) 5411-5422
30. Pinon J.D., Klasse P.J., Jassal S.R., Welson S., Weber J., Brighty D.W., and Sattentau Q.J. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J. Virol. 77 18 (2003) 9922-9930
31. Rieger J., Wick W., and Weller M. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42 4 (2003) 379-389
32. Saphire A.C., Bobardt M.D., Zhang Z., David G., and Gallay P.A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75 19 (2001) 9187-9200
33. Shukla D., and Spear P.G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108 4 (2001) 503-510
34. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 6 (1998) 735-745
35. Sutton R.E., and Littman D.R. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70 10 (1996) 7322-7326
36. Takagi S., Hirata T., Agata K., Mochii M., Eguchi G., and Fujisawa H. The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron 7 2 (1991) 295-307
37. Takenouchi N., Jones K.S., Lisinski I., Fugo K., Yao K., Cushman S.W., Ruscetti F.W., and Jacobson S. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J. Virol. 81 3 (2007) 1506-1510
38. Trejo S.R., and Ratner L. The HTLV receptor is a widely expressed protein. Virology 268 1 (2000) 41-48
39. Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24 39 (2005) 5931-5937